# Vitamin C, Hydrocortisone and Thiamine for Septic Shock

> **NCT03592693** · PHASE2 · TERMINATED · sponsor: **University of Athens** · enrollment: 24 (actual)

## Conditions studied

- Shock, Septic

## Interventions

- **DRUG:** Combined Vitamin C and Stress-Dose Hydrocortisone
- **DRUG:** Placebo plus placebo

## Key facts

- **NCT ID:** NCT03592693
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-06
- **Primary completion:** 2023-01-16
- **Final completion:** 2023-01-16
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Low rate of enrollment; publication of relevant results by other groups
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592693, "Vitamin C, Hydrocortisone and Thiamine for Septic Shock". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03592693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*